9.30

6.72% -0.67

Pre-market: 9.15 -0.15 -1.61%

Arcturus Therapeutics Holdings Inc (ARCT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Arcturus Therapeutics Holdings Inc stock is traded at $9.30, with a volume of 1.02M. It is down -6.72% in the last 24 hours and down -58.78% over the past month. Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

Previous Close:

$9.97

Open:

$10.12

24h Volume:

1.02M

Relative Volume:

0.87

Market Cap:

$252.54M

Revenue:

$157.75M

Net Income/Loss:

$-29.73M

P/E Ratio:

-8.0172

EPS:

-1.16

Net Cash Flow:

$-21.00M

1W Performance:

-12.18%

1M Performance:

-58.78%

6M Performance:

-27.51%

1Y Performance:

-48.33%

1-Day Range:

$9.23

$10.12

1-Week Range:

$9.23

$10.50

52-Week Range:

$8.04

$24.17

Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile

Name

Arcturus Therapeutics Holdings Inc

Sector

Healthcare (1136)

Industry

Biotechnology (633)

Phone

(858) 900-2660

Address

10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA

Employee

176

Twitter

@ArcturusRx

Next Earnings Date

2024-11-07

Latest SEC Filings

ARCT's Discussions on Twitter

Compare ARCT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ARCT Arcturus Therapeutics Holdings Inc	9.30	270.73M	157.75M	-29.73M	-21.00M	-1.16
VRTX Vertex Pharmaceuticals Inc	426.00	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.25	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	434.07	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	826.28	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.23	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-24-25	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-23-25	Downgrade	Citigroup	Buy → Neutral
Oct-22-25	Downgrade	Guggenheim	Buy → Neutral
Sep-04-25	Resumed	H.C. Wainwright	Buy
May-28-25	Initiated	Scotiabank	Sector Outperform
Jan-28-25	Initiated	BTIG Research	Buy
Aug-12-24	Initiated	Leerink Partners	Outperform
Dec-13-23	Initiated	Canaccord Genuity	Buy
Jul-24-23	Initiated	William Blair	Outperform
May-11-23	Upgrade	H.C. Wainwright	Neutral → Buy
Nov-14-22	Resumed	Wells Fargo	Overweight
Nov-10-22	Downgrade	Robert W. Baird	Neutral → Underperform
Nov-03-22	Upgrade	Citigroup	Neutral → Buy
Nov-02-22	Upgrade	Barclays	Underweight → Equal Weight
Aug-10-22	Downgrade	Raymond James	Mkt Perform → Underperform
Jul-19-22	Resumed	Cantor Fitzgerald	Overweight
May-11-22	Upgrade	Robert W. Baird	Underperform → Neutral
Apr-21-22	Downgrade	Citigroup	Buy → Neutral
Jan-31-22	Upgrade	Raymond James	Underperform → Mkt Perform
Aug-12-21	Downgrade	Raymond James	Mkt Perform → Underperform
Aug-11-21	Downgrade	Goldman	Neutral → Sell
Aug-10-21	Downgrade	Robert W. Baird	Neutral → Underperform
Jul-02-21	Initiated	Cantor Fitzgerald	Overweight
Jun-25-21	Resumed	Goldman	Neutral
Jun-21-21	Downgrade	Barclays	Equal Weight → Underweight
Jun-04-21	Resumed	Robert W. Baird	Neutral
Feb-17-21	Downgrade	B. Riley Securities	Neutral → Sell
Jan-19-21	Downgrade	B. Riley Securities	Buy → Neutral
Jan-15-21	Downgrade	B. Riley Securities	Buy → Neutral
Jan-07-21	Initiated	Wells Fargo	Overweight
Dec-29-20	Downgrade	Barclays	Overweight → Equal Weight
Dec-29-20	Downgrade	H.C. Wainwright	Buy → Neutral
Dec-29-20	Downgrade	Raymond James	Outperform → Mkt Perform
Dec-29-20	Downgrade	Robert W. Baird	Outperform → Neutral
Dec-23-20	Downgrade	ROTH Capital	Buy → Sell
Dec-08-20	Reiterated	B. Riley Securities	Buy
Dec-07-20	Reiterated	B. Riley Securities	Buy
Oct-26-20	Initiated	Barclays	Overweight
Oct-06-20	Initiated	Citigroup	Buy
Aug-26-20	Initiated	Piper Sandler	Overweight
Jul-30-20	Resumed	ROTH Capital	Buy
Jul-16-20	Initiated	Raymond James	Outperform
Jul-13-20	Initiated	B. Riley FBR	Buy
Jun-09-20	Downgrade	WBB Securities	Buy → Hold
Feb-11-20	Initiated	Robert W. Baird	Outperform
Feb-07-20	Initiated	Guggenheim	Buy
Feb-06-20	Initiated	Guggenheim	Buy
Apr-05-19	Initiated	H.C. Wainwright	Buy
Sep-20-18	Upgrade	WBB Securities	Buy → Strong Buy
Jan-22-18	Initiated	Chardan Capital Markets	Buy

View All

Arcturus Therapeutics Holdings Inc Stock (ARCT) Latest News

04:01 AM

What MACD signals say about Arcturus Therapeutics Holdings Inc.M&A Rumor & Pattern Based Trade Signal System - newser.com

04:01 AM

03:43 AM

Can momentum traders help lift Arcturus Therapeutics Holdings Inc.Weekly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com

03:43 AM

Nov 03, 2025

Ongoing Investigation Into Arcturus Therapeutics Holdings Inc. (ARCT): Contact Levi & Korsinsky About Potential Fraud - ACCESS Newswire

Nov 03, 2025

Protect Your Investment: Contact Levi & Korsinsky About the Arcturus Therapeutics Holdings Inc. (ARCT) Investigation - ACCESS Newswire

Nov 03, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Arcturus Therapeutics Holdings Inc. (ARCT) And Encourages Investors to Connect - ACCESS Newswire

Nov 03, 2025

Earnings Preview: Arcturus Therapeutics (ARCT) Q3 Earnings Expected to Decline - Yahoo Finance

Nov 03, 2025

Arcturus Therapeutics Holdings Inc. stock volume spike explainedTrade Exit Summary & Stepwise Trade Signal Implementation - newser.com

Nov 03, 2025

How Arcturus Therapeutics Holdings Inc. stock valuations compare to rivals2025 Fundamental Recap & Community Driven Trade Alerts - newser.com

Nov 03, 2025

Is Arcturus Therapeutics Holdings Inc. stock cheap at current valuationJuly 2025 Action & Fast Momentum Stock Entry Tips - newser.com

Nov 03, 2025

Published on: 2025-11-03 05:43:35 - newser.com

Nov 03, 2025

Can Arcturus Therapeutics Holdings Inc. stock beat market expectations this quarterEarnings Recap Report & Fast Gaining Stock Reports - newser.com

Nov 03, 2025

Advanced analytics toolkit walkthrough for Arcturus Therapeutics Holdings Inc.2025 Top Gainers & Community Verified Swing Trade Signals - newser.com

Nov 03, 2025

Nov 02, 2025

Real time scanner hits for Arcturus Therapeutics Holdings Inc. explainedJuly 2025 Breakouts & Precise Trade Entry Recommendations - newser.com

Nov 02, 2025

What candlestick patterns are forming on Arcturus Therapeutics Holdings Inc.Market Growth Summary & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 02, 2025

Published on: 2025-11-02 01:11:00 - newser.com

Nov 02, 2025

Nov 01, 2025

How Arcturus Therapeutics Holdings Inc. stock compares to market leadersVolume Spike & Advanced Technical Signal Analysis - newser.com

Nov 01, 2025

How to forecast Arcturus Therapeutics Holdings Inc. trends using time seriesQuarterly Growth Report & Accurate Intraday Trading Signals - newser.com

Nov 01, 2025

Published on: 2025-11-01 04:30:36 - newser.com

Nov 01, 2025

Oct 31, 2025

Is Arcturus Therapeutics Holdings Inc. stock attractive for income investorsJuly 2025 Selloffs & Safe Entry Momentum Tips - newser.com

Oct 31, 2025

Is Arcturus Therapeutics Holdings Inc. stock ready for a breakoutTrade Volume Report & High Conviction Trade Alerts - newser.com

Oct 31, 2025

Sumitomo Mitsui Trust Group, Inc. Expands Stake in Arcturus Therapeutics Holdings Inc. - GuruFocus

Oct 31, 2025

Potential Securities Fraud: Levi & Korsinsky Investigates Arcturus Therapeutics Holdings Inc. (ARCT) - ACCESS Newswire

Oct 31, 2025

High Growth Tech Stocks In US With Promising Potential - simplywall.st

Oct 31, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arcturus Therapeutics Holdings Inc. (ARCT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Oct 31, 2025

2025-10-31 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arcturus Therapeutics Holdings Inc. (ARCT) and Encourages Investors to Learn More About the Investigation | NDAQ:ARCT | Press Release - Stockhouse

Oct 31, 2025

How currency fluctuations impact Arcturus Therapeutics Holdings Inc. stockPortfolio Update Report & Proven Capital Preservation Methods - newser.com

Oct 31, 2025

What technical models suggest about Arcturus Therapeutics Holdings Inc.’s comebackJuly 2025 EndofMonth & Weekly Momentum Stock Picks - newser.com

Oct 31, 2025

Arcturus Therapeutics Holdings (ARCT) Price Target Decreased by 30.87% to 45.67 - MSN

Oct 31, 2025

Oct 30, 2025